Curtiss B. Cook, MD Mary E. Boyle, CNP, BC-ADM, CDE Nancy S. Cisar, MSN, RN, APRN, BC Victoria Miller-Cage, MS, FNP Peggy Bourgeois, APRN, MN, CNS, CDE Lori R. Roust, MD Steven A. Smith, MD Richard S. Zimmerman, MD From the Division of Endocrinology (Dr Cook, Ms Boyle, Dr Roust), the Department of Nursing (Ms Cisar, Ms Miller-Cage), and the Department of Neurologic Surgery (Dr Zimmerman), Mayo Clinic, Scottsdale, Arizona, and Division of Endocrinology, Diabetes, Nutrition, and Metabolism and Department of Health Care Policy and Research, Mayo Clinic, Rochester. Correspondence to Curtiss B. Cook, MD, Division of Endocrinology, Mayo Clinic Scottsdale, 13400 East Shea Boulevard, Scottsdale, AZ 85259. DOI: 10.1177/0145721705281563 Insulin Pump Therapy in Hospital Setting 849 Cook et al Use of Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy in the Hospital Setting Proposed Guidelines and Outcome Measures Purpose Individuals whose diabetes is being treated in the outpa- tient setting via an insulin pump often wish to maintain this therapy during hospitalization. The authors propose guidelines for management of patients on insulin pumps who require a hospital admission. Methods A collaborative interinstitutional task force reviewed current available information regarding the use of insulin pumps in the hospital. Results There was little information in the medical literature on how to manage individuals on established insulin pump therapy during a hospital stay. The task force believed that a policy that promotes patient independence through continuation of insulin pump therapy while ensuring patient safety was possible. A set of contraindications for continued use of pump therapy in the hospital are proposed. A sample patient consent form and order set are presented. Finally, measures that can be used to assess effectiveness of an inpatient insulin pump policy are outlined.